FDA Panel Considers Ban on Electric Stimulation Devices for Aversion Therapy
Today the FDA Neurological Devices Panel convened to consider a ban on electric stimulation devices for aversive conditioning in patients inflicting self-harm and displaying aggressive behavior. Though the panel made no decision today, it stated that its primary concern is the safety and wellbeing of patients receiving this therapy and recognized the need for clinical trials to examine the benefits and risks of electric stimulation devices in these patients. Panel member Wayne Goodman, MD, Professor and Chair of the Department of Psychiatry, and Professor of Neuroscience at the Icahn School of Medicine at Mount Sinai, said that though many patients have seen benefits from this treatment he is “not ready to say we should disseminate this treatment to others.”
-Dr. Wayne Goodman, Professor, Chair, Psychiatry, Professor, Neuroscience, Icahn School of Medicine at Mount Sinai
Mount Sinai Establishes Steven S. Elbaum Family Center for Caregiving
May 20, 2025 View All Press Releases
Mount Sinai Surgeons Perform First Heart-Liver-Kidney Transplants in New York State
May 20, 2025 View All Press Releases
Mount Sinai Launches AI Small Molecule Drug Discovery Center
Apr 02, 2025 View All Press Releases